Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Anti-androgenicity can only be evaluated using a weight of evidence approach.

Melching-Kollmuß S, Fussell KC, Buesen R, Dammann M, Schneider S, Tennekes H, van Ravenzwaay B.

Regul Toxicol Pharmacol. 2014 Feb;68(1):175-92. doi: 10.1016/j.yrtph.2013.10.004. Epub 2013 Oct 31. Review.

PMID:
24184466
2.

The effects of inhalation anaesthetics on common clinical pathology parameters in laboratory rats.

Deckardt K, Weber I, Kaspers U, Hellwig J, Tennekes H, van Ravenzwaay B.

Food Chem Toxicol. 2007 Sep;45(9):1709-18. Epub 2007 Mar 16.

PMID:
17459552
3.

The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessment.

Tennekes H, Kaufmann W, Dammann M, van Ravenzwaay B.

Regul Toxicol Pharmacol. 2004 Dec;40(3):293-304.

PMID:
15546683
4.
5.

A Wistar rat strain prone to spontaneous liver tumor development: implications for carcinogenic risk assessment.

van Ravenzwaay B, Tennekes H.

Regul Toxicol Pharmacol. 2002 Aug;36(1):86-95.

PMID:
12383721
6.

The kinetics of nuclear polyploidization and tumour formation in livers of CF-1 mice exposed to dieldrin.

van Ravenzwaay B, Tennekes H, Stöhr M, Kunz W.

Carcinogenesis. 1987 Feb;8(2):265-9.

PMID:
3802410
7.

Quantitative aspects of enhanced liver tumour formation in CF-1 mice by dieldrin.

Tennekes H, van Ravenzwaay B, Kunz HW.

Carcinogenesis. 1985 Oct;6(10):1457-62.

PMID:
4042275
8.

Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.

Kunz W, Schaude G, Schwarz M, Tennekes H.

Carcinog Compr Surv. 1982;7:111-25. Review. No abstract available.

PMID:
7039825

Supplemental Content

Loading ...
Support Center